New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Prescribing rates have fallen slightly in the last two years, possibly because of growing caution in some countries about possible long-term effects.
But researchers said the use of the puberty-stalling hormones remained relatively high at a time when overseas jurisdictions were becoming increasingly restrictive about their use.
Exploring lived experience provides insights into the multiple ways that lack of affordability prevents access to medicines: directly, through interaction with other barriers to access including transport, by damaging trust and reducing acceptability of services, and by making participants less able to deal with mistakes made by health professionals.
General Practitioners Aotearoa opposes the Government’s recent decision to fund specific smoking cessation products, namely vaping kits. Read...
Health New Zealand – Te Whatu Ora’s executive team is set to change as new Health Minister Simeon Brown says he believes a refreshed line-up is necessary to ensure the entity’s focus is centred on the Government’s health targets. Read...
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI